首页 › 基金 › GREAT POINT PARTNERS LLC › ABCL

GREAT POINT PARTNERS LLC 对 ABCL 的持仓历史

ABCELLERA BIOLOGICS INC · 医疗保健

GREAT POINT PARTNERS LLC 在 Q3 2026 的 13F 申报中披露持有 ABCL(ABCELLERA BIOLOGICS INC)600,000 股,市值约 US$8.8M,约占其申报组合的 2.19%,在其申报持仓中市值排名第 19 位。 GREAT POINT PARTNERS LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)600.00K 股
申报持仓市值$8.75M
组合权重2.19%
首次申报Q3 2026
最近变动新进
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

GREAT POINT PARTNERS LLC 对 ABCL 的持仓演变

GREAT POINT PARTNERS LLC 于 Q3 2026 首次披露 ABCL 持仓:600,000 股(约 US$8.8M)。

逐季持仓明细

季度股数金额变化
Q3 2026 600.00K $8.75M 新进

关于 ABCL 与 13F 数据

ABCL(ABCELLERA BIOLOGICS INC)属于医疗保健行业。我们追踪的基金中还有 46 只申报持有 ABCL,申报仓位最大的包括:BAKER BROS. ADVISORS LP (US$481.6M), ArrowMark Colorado Holdings LLC (US$70.4M), ADAR1 Capital Management, LLC (US$12.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ABCL 的基金

查看 ABCL 的全部基金持有人 →

常见问题

How long has GREAT POINT PARTNERS LLC held ABCL?

GREAT POINT PARTNERS LLC has disclosed ABCL holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is GREAT POINT PARTNERS LLC's current position in ABCL?

As of Q3 2026, GREAT POINT PARTNERS LLC holds 600.00K shares of ABCL (ABCELLERA BIOLOGICS INC), valued at $8.75M, representing 2.19% of its reported portfolio and ranking #19.

Has GREAT POINT PARTNERS LLC been buying or selling ABCL?

In the latest 13F filing (Q3 2026), GREAT POINT PARTNERS LLC newly opened its position in ABCL.

Which other funds hold ABCL?

Other major institutional holders of ABCL include BAKER BROS. ADVISORS LP, ArrowMark Colorado Holdings LLC, ADAR1 Capital Management, LLC, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.